Advanced search
1 file | 484.94 KB Add to list

Epidemiology and surveillance of human (neuro)cysticercosis in Europe : is enhanced surveillance required?

Author
Organization
Abstract
Objectives To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000-2016. Methods (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians and a search for relevant 'International Statistical Classification of Diseases and Related Health Problems' (ICD)-based data. Results Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3489 cases (N)CC cases were coded: 832 in Italy, eight in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden. Conclusion Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.
Keywords
Public Health, Environmental and Occupational Health, Parasitology, Infectious Diseases, GLIOBLASTOMA-MULTIFORME, HUMAN CYSTICERCOSIS, NEUROCYSTICERCOSIS, DIAGNOSIS, COUNTRIES, DISEASES, STILL, TIME, neurocysticercosis, Europe, epidemiology

Downloads

  • published article.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 484.94 KB

Citation

Please use this url to cite or link to this publication:

MLA
Abraham, Annette, et al. “Epidemiology and Surveillance of Human (Neuro)Cysticercosis in Europe : Is Enhanced Surveillance Required?” TROPICAL MEDICINE & INTERNATIONAL HEALTH, vol. 25, no. 5, 2020, pp. 566–78, doi:10.1111/tmi.13384.
APA
Abraham, A., Schmidt, V., Kaminski, M., Stelzle, D., De Meijere, R., Bustos, J., … Sylvia Winkler, A. (2020). Epidemiology and surveillance of human (neuro)cysticercosis in Europe : is enhanced surveillance required? TROPICAL MEDICINE & INTERNATIONAL HEALTH, 25(5), 566–578. https://doi.org/10.1111/tmi.13384
Chicago author-date
Abraham, Annette, Veronika Schmidt, Miriam Kaminski, Dominik Stelzle, Robert De Meijere, Javier Bustos, Priyadarshi Soumyaranjan Sahu, et al. 2020. “Epidemiology and Surveillance of Human (Neuro)Cysticercosis in Europe : Is Enhanced Surveillance Required?” TROPICAL MEDICINE & INTERNATIONAL HEALTH 25 (5): 566–78. https://doi.org/10.1111/tmi.13384.
Chicago author-date (all authors)
Abraham, Annette, Veronika Schmidt, Miriam Kaminski, Dominik Stelzle, Robert De Meijere, Javier Bustos, Priyadarshi Soumyaranjan Sahu, Hector Hugo Garcia, Branko Bobić, Carmen Cretu, Peter Chiodini, Gunita Deksne, Veronique Dermauw, Brecht Devleesschauwer, Pierre Dorny, Ana Fonseca, Sarah Gabriël, Maria Ángeles Gómez Morales, István Kucsera, Minerva Laranjo‐González, Chiara Trevisan, Manuela Vilhena, Naomi F. Walker, Lorenzo Zammarchi, and Andrea Sylvia Winkler. 2020. “Epidemiology and Surveillance of Human (Neuro)Cysticercosis in Europe : Is Enhanced Surveillance Required?” TROPICAL MEDICINE & INTERNATIONAL HEALTH 25 (5): 566–578. doi:10.1111/tmi.13384.
Vancouver
1.
Abraham A, Schmidt V, Kaminski M, Stelzle D, De Meijere R, Bustos J, et al. Epidemiology and surveillance of human (neuro)cysticercosis in Europe : is enhanced surveillance required? TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2020;25(5):566–78.
IEEE
[1]
A. Abraham et al., “Epidemiology and surveillance of human (neuro)cysticercosis in Europe : is enhanced surveillance required?,” TROPICAL MEDICINE & INTERNATIONAL HEALTH, vol. 25, no. 5, pp. 566–578, 2020.
@article{8653182,
  abstract     = {{Objectives To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000-2016.

Methods (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians and a search for relevant 'International Statistical Classification of Diseases and Related Health Problems' (ICD)-based data.

Results Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3489 cases (N)CC cases were coded: 832 in Italy, eight in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden.

Conclusion Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.}},
  author       = {{Abraham, Annette and Schmidt, Veronika and Kaminski, Miriam and Stelzle, Dominik and De Meijere, Robert and Bustos, Javier and Soumyaranjan Sahu, Priyadarshi and Hugo Garcia, Hector and Bobić, Branko and Cretu, Carmen and Chiodini, Peter and Deksne, Gunita and Dermauw, Veronique and Devleesschauwer, Brecht and Dorny, Pierre and Fonseca, Ana and Gabriël, Sarah and Ángeles Gómez Morales, Maria and Kucsera, István and Laranjo‐González, Minerva and Trevisan, Chiara and Vilhena, Manuela and Walker, Naomi F. and Zammarchi, Lorenzo and Sylvia Winkler, Andrea}},
  issn         = {{1360-2276}},
  journal      = {{TROPICAL MEDICINE & INTERNATIONAL HEALTH}},
  keywords     = {{Public Health,Environmental and Occupational Health,Parasitology,Infectious Diseases,GLIOBLASTOMA-MULTIFORME,HUMAN CYSTICERCOSIS,NEUROCYSTICERCOSIS,DIAGNOSIS,COUNTRIES,DISEASES,STILL,TIME,neurocysticercosis,Europe,epidemiology}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{566--578}},
  title        = {{Epidemiology and surveillance of human (neuro)cysticercosis in Europe : is enhanced surveillance required?}},
  url          = {{http://dx.doi.org/10.1111/tmi.13384}},
  volume       = {{25}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: